James R Priest1, Scott R Ceresnak1, Frederick E Dewey2, Lindsey E Malloy-Walton1, Kyla Dunn3, Megan E Grove2, Marco V Perez2, Katsuhide Maeda4, Anne M Dubin5, Euan A Ashley6. 1. Division of Pediatric Cardiology, Stanford University School of Medicine, Stanford University, Stanford, California; Child Health Research Institute; Stanford Cardiovascular Institute, Stanford University School of Medicine, Stanford, California. 2. Division of Cardiovascular Medicine; Stanford Cardiovascular Institute, Stanford University School of Medicine, Stanford, California. 3. Children's Heart Center, Lucile Packard Children's Hospital at Stanford, Palo Alto, California; Stanford Cardiovascular Institute, Stanford University School of Medicine, Stanford, California. 4. Division of Cardiothoracic Surgery; Child Health Research Institute; Stanford Cardiovascular Institute, Stanford University School of Medicine, Stanford, California. 5. Division of Pediatric Cardiology, Stanford University School of Medicine, Stanford University, Stanford, California; Stanford Cardiovascular Institute, Stanford University School of Medicine, Stanford, California. 6. Division of Cardiovascular Medicine; Child Health Research Institute; Stanford Cardiovascular Institute, Stanford University School of Medicine, Stanford, California. Electronic address: euan@stanford.edu.
Abstract
BACKGROUND: The advent of clinical next generation sequencing is rapidly changing the landscape of rare disease medicine. Molecular diagnosis of long QT syndrome (LQTS) can affect clinical management, including risk stratification and selection of pharmacotherapy on the basis of the type of ion channel affected, but results from the current gene panel testing requires 4-16 weeks before return to clinicians. OBJECTIVE: A term female infant presented with 2:1 atrioventricular block and ventricular arrhythmias consistent with perinatal LQTS, requiring aggressive treatment including epicardial pacemaker and cardioverter-defibrillator implantation and sympathectomy on day of life 2. We sought to provide a rapid molecular diagnosis for the optimization of treatment strategies. METHODS: We performed Clinical Laboratory Improvement Amendments-certified rapid whole genome sequencing (WGS) with a speed-optimized bioinformatics platform to achieve molecular diagnosis at 10 days of life. RESULTS: We detected a known pathogenic variant in KCNH2 that was demonstrated to be paternally inherited by follow-up genotyping. The unbiased assessment of the entire catalog of human genes provided by WGS revealed a maternally inherited variant of unknown significance in a novel gene. CONCLUSION: Rapid clinical WGS provides faster and more comprehensive diagnostic information at 10 days of life than does standard gene panel testing. In selected clinical scenarios such as perinatal LQTS, rapid WGS can provide more timely and clinically actionable information than can a standard commercial test.
BACKGROUND: The advent of clinical next generation sequencing is rapidly changing the landscape of rare disease medicine. Molecular diagnosis of long QT syndrome (LQTS) can affect clinical management, including risk stratification and selection of pharmacotherapy on the basis of the type of ion channel affected, but results from the current gene panel testing requires 4-16 weeks before return to clinicians. OBJECTIVE: A term female infant presented with 2:1 atrioventricular block and ventricular arrhythmias consistent with perinatal LQTS, requiring aggressive treatment including epicardial pacemaker and cardioverter-defibrillator implantation and sympathectomy on day of life 2. We sought to provide a rapid molecular diagnosis for the optimization of treatment strategies. METHODS: We performed Clinical Laboratory Improvement Amendments-certified rapid whole genome sequencing (WGS) with a speed-optimized bioinformatics platform to achieve molecular diagnosis at 10 days of life. RESULTS: We detected a known pathogenic variant in KCNH2 that was demonstrated to be paternally inherited by follow-up genotyping. The unbiased assessment of the entire catalog of human genes provided by WGS revealed a maternally inherited variant of unknown significance in a novel gene. CONCLUSION: Rapid clinical WGS provides faster and more comprehensive diagnostic information at 10 days of life than does standard gene panel testing. In selected clinical scenarios such as perinatal LQTS, rapid WGS can provide more timely and clinically actionable information than can a standard commercial test.
Authors: E S Kaufman; S G Priori; C Napolitano; P J Schwartz; S Iyengar; R C Elston; A H Schnell; E Z Gorodeski; G Rammohan; N O Bahhur; D Connuck; L Verrilli; D S Rosenbaum; A M Brown Journal: J Cardiovasc Electrophysiol Date: 2001-04
Authors: Elisa Carniel; Matthew R G Taylor; Gianfranco Sinagra; Andrea Di Lenarda; Lisa Ku; Pamela R Fain; Mark M Boucek; Jean Cavanaugh; Snjezana Miocic; Dobromir Slavov; Sharon L Graw; Jennie Feiger; Xiao Zhong Zhu; Dmi Dao; Debra A Ferguson; Michael R Bristow; Luisa Mestroni Journal: Circulation Date: 2005-07-05 Impact factor: 29.690
Authors: Frederick E Dewey; Megan E Grove; Cuiping Pan; Benjamin A Goldstein; Jonathan A Bernstein; Hassan Chaib; Jason D Merker; Rachel L Goldfeder; Gregory M Enns; Sean P David; Neda Pakdaman; Kelly E Ormond; Colleen Caleshu; Kerry Kingham; Teri E Klein; Michelle Whirl-Carrillo; Kenneth Sakamoto; Matthew T Wheeler; Atul J Butte; James M Ford; Linda Boxer; John P A Ioannidis; Alan C Yeung; Russ B Altman; Themistocles L Assimes; Michael Snyder; Euan A Ashley; Thomas Quertermous Journal: JAMA Date: 2014-03-12 Impact factor: 56.272
Authors: Peter J Schwartz; Silvia G Priori; Marina Cerrone; Carla Spazzolini; Attilio Odero; Carlo Napolitano; Raffaella Bloise; Gaetano M De Ferrari; Catherine Klersy; Arthur J Moss; Wojciech Zareba; Jennifer L Robinson; W Jackson Hall; Paul A Brink; Lauri Toivonen; Andrew E Epstein; Cuilan Li; Dayi Hu Journal: Circulation Date: 2004-03-29 Impact factor: 29.690
Authors: Arne Pfeufer; Serena Sanna; Dan E Arking; Martina Müller; Vesela Gateva; Christian Fuchsberger; Georg B Ehret; Marco Orrú; Cristian Pattaro; Anna Köttgen; Siegfried Perz; Gianluca Usala; Maja Barbalic; Man Li; Benno Pütz; Angelo Scuteri; Ronald J Prineas; Moritz F Sinner; Christian Gieger; Samer S Najjar; W H Linda Kao; Thomas W Mühleisen; Mariano Dei; Christine Happle; Stefan Möhlenkamp; Laura Crisponi; Raimund Erbel; Karl-Heinz Jöckel; Silvia Naitza; Gerhard Steinbeck; Fabio Marroni; Andrew A Hicks; Edward Lakatta; Bertram Müller-Myhsok; Peter P Pramstaller; H-Erich Wichmann; David Schlessinger; Eric Boerwinkle; Thomas Meitinger; Manuela Uda; Josef Coresh; Stefan Kääb; Gonçalo R Abecasis; Aravinda Chakravarti Journal: Nat Genet Date: 2009-03-22 Impact factor: 38.330
Authors: Christopher Newton-Cheh; Mark Eijgelsheim; Kenneth M Rice; Paul I W de Bakker; Xiaoyan Yin; Karol Estrada; Joshua C Bis; Kristin Marciante; Fernando Rivadeneira; Peter A Noseworthy; Nona Sotoodehnia; Nicholas L Smith; Jerome I Rotter; Jan A Kors; Jacqueline C M Witteman; Albert Hofman; Susan R Heckbert; Christopher J O'Donnell; André G Uitterlinden; Bruce M Psaty; Thomas Lumley; Martin G Larson; Bruno H Ch Stricker Journal: Nat Genet Date: 2009-03-22 Impact factor: 38.330
Authors: Daniel S Dodson; Aaron J Goldenberg; Matthew M Davis; Dianne C Singer; Beth A Tarini Journal: Public Health Genomics Date: 2015-03-06 Impact factor: 2.000
Authors: James Rush Priest; Charles Gawad; Kristopher M Kahlig; Joseph K Yu; Thomas O'Hara; Patrick M Boyle; Sridharan Rajamani; Michael J Clark; Sarah T K Garcia; Scott Ceresnak; Jason Harris; Sean Boyle; Frederick E Dewey; Lindsey Malloy-Walton; Kyla Dunn; Megan Grove; Marco V Perez; Norma F Neff; Richard Chen; Katsuhide Maeda; Anne Dubin; Luiz Belardinelli; John West; Christian Antolik; Daniela Macaya; Thomas Quertermous; Natalia A Trayanova; Stephen R Quake; Euan A Ashley Journal: Proc Natl Acad Sci U S A Date: 2016-09-28 Impact factor: 11.205